Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") received an inquiry letter from the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") on February 12, 2026, regarding the Company's application to issue convertible bonds to unspecified objects (Inquiry Letter [2026] No. 120011). The SZSE's listing review agency conducted a review of the Company's application documents for the issuance of convertible bonds and formulated inquiry questions. In accordance with the requirements of the inquiry letter, the Company, together with relevant intermediaries, carefully stu
002550SZSE
Announcement on the Response to the Inquiry Letter Regarding the Issuance of Convertible Bonds to Unspecified Objects and Update of Application Documents
✨ AI Summary
This announcement details the response from Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. to the Shenzhen Stock Exchange's inquiry regarding their application to issue convertible bonds. The company has addressed the inquiry and updated its application documents accordingly. The issuance is subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission, with uncertainties regarding the approval timeline. Investors are advised to be aware of the associated risks.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.